Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL184 vs HRIG in Rabies PEP for Children
NCT00708084Phase 2Completed
- Sponsor
- Crucell
- Start
- May 2008
- Primary completion
- Oct 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CL184 in rabies, sponsored by Crucell. Started May 2008; status: completed.
02
Drugs
CL184
03
Conditions
rabies
Beyond the preview
Go deeper on NCT00708084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708084.